Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers
β Scribed by A. Pacifico; L.H. Goldberg; K. Peris; S. Chimenti; G. Leone; H.N. Ananthaswamy
- Book ID
- 108669839
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 324 KB
- Volume
- 158
- Category
- Article
- ISSN
- 0007-0963
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract A cyclinβdependent kinase inhibitor CDKN2A (p16/Ink4a) is a tumor suppressor and upregulated in cellular senescence. CDKN2A promoter methylation and gene silencing are associated with the CpG island methylator phenotype (CIMP) in colon cancer. However, prognostic significance of CDKN2A
## Abstract Cutaneous human papillomavirus (HPV) may be associated with the development of nonmelanoma skin cancer (NMSC), as suggested by reports of HPV DNA in NMSC tumors. HPV has also been investigated as an NMSC risk factor in epidemiologic studies, although findings vary across studies that us